1-13 of 13
kinase inhibitors
Close
Sort by
Journal Articles

Relapsed CLL: sequencing, combinations, and novel agents

Jennifer R. Brown
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 248–255.
https://doi.org/10.1182/asheducation-2018.1.248
Published: 2018
Journal Articles

Optimizing frontline therapy of CLL based on clinical and biological factors

Kirsten Fischer, Michael Hallek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 338–345.
https://doi.org/10.1182/asheducation-2017.1.338
Published: 2017
Journal Articles

Patterns of resistance to B cell–receptor pathway antagonists in chronic lymphocytic leukemia and strategies for management

Jennifer A. Woyach
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 355–360.
https://doi.org/10.1182/asheducation-2015.1.355
Published: 2015
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015
Journal Articles

B-cell receptor pathway modulators in NHL

Kristie A. Blum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 82–91.
https://doi.org/10.1182/asheducation-2015.1.82
Published: 2015
Journal Articles

BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma

Adrian Wiestner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 125–134.
https://doi.org/10.1182/asheducation-2014.1.125
Published: 2014
Journal Articles

Monitoring after successful therapy for chronic myeloid leukemia

Susan Branford
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 105–110.
https://doi.org/10.1182/asheducation.V2012.1.105.3798223
Published: 2012
Journal Articles

Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

Adrian Wiestner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 88–96.
https://doi.org/10.1182/asheducation.V2012.1.88.3801172
Published: 2012
Journal Articles

Minimal Residual Disease and Discontinuation of Therapy in Chronic Myeloid Leukemia: Can We Aim at a Cure?

Junia V. Melo, David M. Ross
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 136–142.
https://doi.org/10.1182/asheducation-2011.1.136
Published: 2011
Journal Articles

Novel Agents in CML Therapy: Tyrosine Kinase Inhibitors and Beyond

Junia V. Melo, Charles Chuah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 427–435.
https://doi.org/10.1182/asheducation-2008.1.427
Published: 2008
Journal Articles

Medical Management of CML

Neil P. Shah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 371–375.
https://doi.org/10.1182/asheducation-2007.1.371
Published: 2007
Journal Articles

Defining and Managing Imatinib Resistance

Michael J. Mauro
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 219–225.
https://doi.org/10.1182/asheducation-2006.1.219
Published: 2006
Journal Articles

ABL Kinase Inhibitor Therapy for CML: Baseline Assessments and Response Monitoring

Timothy Hughes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 211–218.
https://doi.org/10.1182/asheducation-2006.1.211
Published: 2006